|
THE
FEMALE HEALTH COMPANY REPORTS:
AS NUMBER OF WOMEN
WITH HIV/AIDS GROWS,
PUBLIC HEALTH OFFICIALS LOOK TO FEMALE CONDOM PROGRAMS
National Conference of State Legislatures Told of Cost-Effectiveness and
Availability
of The Female Condom by President of The Female Health Company
CHICAGO, 19 July 2000 -
With U. S. Centers for Disease Control statistics showing increasing
sexually transmitted disease (STD) including HIV/AIDS infection among
American women, public health officials and policymakers are examining
ways to help women protect themselves and their families from the
dreaded diseases. Recent studies show that having an effective condom
distribution program including The Female Condom™ can be a
cost-effective tool in preventing HIV and other STDs.
"Studies show that women counseled about the importance of
consistently using a protective method, and introduced to a method which
is under their control -- The Female Condom -- show a high level of
determination to try it and to continue to use
it," said Mary Ann Leeper, Ph.D., president of The Female Health
Company, manufacturer and marketer of The Female Condom. "The cost
savings are realized with increased protected sex acts and subsequent
decreased infections, thus preventing significant public health treatment
and care spending."
Dr. Leeper presented the results of two studies and introduced a model
public health program to delegates attending the National Conference of
State Legislatures annual meeting in Chicago today.
At the recent International AIDS Conference in Durban, South Africa, Peter
Lamty, senior vice president of Family Health International from North
Carolina, stated in his opening plenary session that while other
women-controlled options for prevention are likely being researched, The
Female Condom will be the only product available for sometime that helps
women worldwide protect themselves against STDs/HIV/AIDS. First introduced
in 1992 after more than six years of product research and development, The
Female Condom is now available in more than 75 countries.
We have learned that The Female Condom must be integrated into existing
health programs," said Dr. Leeper. "These studies reinforce what
our company's experience shows - effective prevention involves a wide
range of individuals and organizations - from health providers and program
managers to community-based and non-governmental organizations. We all
need to work together to slow the spread of STDs/HIV/AIDS."
Dr. Leeper proposed a model for Female Condom programming at the
neighborhood level developed by her company in the past eight years. The
keys to its success are the leadership of a local Community Planning Group
and the strong involvement and participation of all levels of public
health programs - county, city, state and federal. The cost-saving program
design and implementation includes step-by-step guides, multiple funding
streams and training for health care providers.
###
The Female Health Company, based in Chicago, owns
certain worldwide rights to The Female Condom™ including patents that
have been issued in the United States, United Kingdom, Japan, France,
Italy, Germany, Spain, The People’s Republic of China, Canada, New
Zealand, South Korea and Australia. The
Female Condom™ is the only available product controlled by a woman that
protects against sexually transmitted diseases including HIV/AIDS and
unintended pregnancy
Safe
Harbor” Statement under the Private Securities Litigation Reform Action
of 1995: The statements in this release which are not historical fact are
forward-looking statements based upon the Company’s current plans and
strategies, and reflect the Company’s current assessment of the risks
and uncertainties related to its business, including such things as
product demand and market acceptance; the economic and business
environment and the impact of governmental regulations, both in the United
States and abroad; the effects of competitive products and pricing
pressures; currency risks; capacity; efficiency and supply constraints;
and other risks detailed in the Company’s press releases, shareholder
communication and Securities and Exchange Commission filings.
Actual events affecting the
Company and the impact of such events on the Company’s operations may
vary from those currently anticipated.
###
For more
information about the Female Health Company, dial toll-free via fax,
1-800-PRO-INFO and enter company code “FHCO.”
Also, visit the Company’s Web site at www.femalehealth.com.
###
William R. Gargiulo, Jr.
Mary Ann Leeper,Ph.D. Yvette
Anne Venable
231.526.1244
312.280.1119
312.397.6070
If you have any questions
or comments, please send them to us info@femalehealth.com |